Literature DB >> 1371050

Binding of transforming growth factor-beta 1 to methylamine-modified alpha 2-macroglobulin and to binary and ternary alpha 2-macroglobulin-proteinase complexes.

S W Hall1, J LaMarre, L B Marshall, M A Hayes, S L Gonias.   

Abstract

The binding of 125I-labelled transforming growth factor-beta 1 (TGF-beta 1) to human alpha 2-macroglobulin (alpha 2M) was studied by native PAGE and autoradiography. TGF-beta 1 bound preferentially to alpha 2M-methylamine and minimally, if at all, to native alpha 2M. Preparations of alpha 2M-proteinase complex were generated by incubating a standard concentration of alpha 2M (0.4 microM) with different concentrations of trypsin, chymotrypsin or neutrophil elastase (0.04-2.0 microM). The 125I-TGF-beta 1-binding activity depended on the initial ratio of active proteinase to alpha 2M, or r value, used to form the alpha 2M-proteinase complex. With all three proteinases, r values of 2 or greater yielded preparations with unchanged or decreased TGF-beta 1-binding activity relative to native alpha 2M. By contrast, r values near 1 yielded preparations with significantly increased TGF-beta 1-binding activity. The results of [3H]thymidine-incorporation studies performed in mouse keratinocytes were consistent with the 125I-TGF-beta-binding experiments. alpha 2M-trypsin and alpha 2M-chymotrypsin prepared at an r value of 1.0 counteracted the activity of TGF-beta 1, whereas the equivalent complexes prepared at an r value of 3.0 had no effect. As determined by SDS/PAGE, 125I-TGF-beta 1 binding to alpha 2M-methylamine was at least 80% non-covalent. Reaction of alpha 2M-methylamine with iodoacetamide or 5,5'-dithiobis-(2-nitrobenzoic acid) decreased the percentage of covalent binding but had no effect on total binding. Neuraminidase treatment had no effect on the binding of 125I-TGF-beta 1 to alpha 2M-methylamine. Cleavage of the 'bait regions' in alpha 2M-methylamine by prolonged treatment with trypsin also had no effect. These studies suggest that TGF-beta 1 binding to alpha 2M is enhanced by conformational change in the proteinase inhibitor resulting from reaction with proteinase or amine. If both proteinase-binding sites in a single alpha 2M molecule are occupied, TGF-beta 1-binding activity is decreased or perhaps eliminated.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1371050      PMCID: PMC1130723          DOI: 10.1042/bj2810569

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  52 in total

1.  Differential inhibition of transforming growth factor beta 1 and beta 2 activity by alpha 2-macroglobulin.

Authors:  D Danielpour; M B Sporn
Journal:  J Biol Chem       Date:  1990-04-25       Impact factor: 5.157

2.  p-Nitrophenyl-p'-guanidinobenzoate HCl: a new active site titrant for trypsin.

Authors:  T Chase; E Shaw
Journal:  Biochem Biophys Res Commun       Date:  1967-11-30       Impact factor: 3.575

3.  Mapping the extended substrate binding site of cathepsin G and human leukocyte elastase. Studies with peptide substrates related to the alpha 1-protease inhibitor reactive site.

Authors:  K Nakajima; J C Powers; B M Ashe; M Zimmerman
Journal:  J Biol Chem       Date:  1979-05-25       Impact factor: 5.157

4.  A sensitive new substrate for chymotrypsin.

Authors:  E G DelMar; C Largman; J W Brodrick; M C Geokas
Journal:  Anal Biochem       Date:  1979-11-01       Impact factor: 3.365

5.  Structural characterization of human alpha2-macroglobulin subunits.

Authors:  R P Swenson; J B Howard
Journal:  J Biol Chem       Date:  1979-06-10       Impact factor: 5.157

6.  Nerve growth factor binds to serum alpha-2-macroglobulin.

Authors:  H Ronne; H Anundi; L Rask; P A Peterson
Journal:  Biochem Biophys Res Commun       Date:  1979-03-15       Impact factor: 3.575

7.  The electrophoretically 'slow' and 'fast' forms of the alpha 2-macroglobulin molecule.

Authors:  A J Barrett; M A Brown; C A Sayers
Journal:  Biochem J       Date:  1979-08-01       Impact factor: 3.857

8.  Alpha 2-macroglobulin and serum preferentially counteract the mitoinhibitory effect of transforming growth factor-beta 2 in rat hepatocytes.

Authors:  J LaMarre; G K Wollenberg; J Gauldie; M A Hayes
Journal:  Lab Invest       Date:  1990-05       Impact factor: 5.662

9.  Binding of recombinant interleukin-1 beta to the third complement component and alpha 2-macroglobulin after activation of serum by immune complexes.

Authors:  W Borth; A Urbanski; R Prohaska; M Susanj; T A Luger
Journal:  Blood       Date:  1990-06-15       Impact factor: 22.113

10.  Physical and chemical properties of human plasma alpha2-macroglobulin.

Authors:  P K Hall; R C Roberts
Journal:  Biochem J       Date:  1978-07-01       Impact factor: 3.857

View more
  9 in total

1.  A 16-amino acid peptide from human alpha2-macroglobulin binds transforming growth factor-beta and platelet-derived growth factor-BB.

Authors:  D J Webb; D W Roadcap; A Dhakephalkar; S L Gonias
Journal:  Protein Sci       Date:  2000-10       Impact factor: 6.725

2.  Beta-amyloid peptide binds equivalently to binary and ternary alpha2-macroglobulin-protease complexes.

Authors:  Joseph M Mettenburg; Steven L Gonias
Journal:  Protein J       Date:  2005-02       Impact factor: 2.371

3.  Characterization and immunohistochemical localization of alpha 2-macroglobulin receptor (low-density lipoprotein receptor-related protein) in human brain.

Authors:  B B Wolf; M B Lopes; S R VandenBerg; S L Gonias
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

4.  Proteinases are isoform-specific regulators of the binding of transforming growth factor beta to alpha 2-macroglobulin.

Authors:  D J Webb; A M Weaver; T L Atkins-Brady; S L Gonias
Journal:  Biochem J       Date:  1996-12-01       Impact factor: 3.857

5.  Binding of platelet-derived growth factor-BB and transforming growth factor-beta 1 to alpha 2-macroglobulin in vitro and in vivo: comparison of receptor-recognized and non-recognized alpha 2-macroglobulin conformations.

Authors:  K P Crookston; D J Webb; J Lamarre; S L Gonias
Journal:  Biochem J       Date:  1993-07-15       Impact factor: 3.857

6.  Differences in the binding of transforming growth factor beta 1 to the acute-phase reactant and constitutively synthesized alpha-macroglobulins of rat.

Authors:  D J Webb; K P Crookston; N L Figler; J Lamarre; S L Gonias
Journal:  Biochem J       Date:  1995-12-01       Impact factor: 3.857

7.  Characterization of the interaction between alpha2-macroglobulin and fibroblast growth factor-2: the role of hydrophobic interactions.

Authors:  Smitha Mathew; Sanja Arandjelovic; Wayne F Beyer; Steven L Gonias; Salvatore V Pizzo
Journal:  Biochem J       Date:  2003-08-15       Impact factor: 3.857

8.  Hepcidin bound to α2-macroglobulin reduces ferroportin-1 expression and enhances its activity at reducing serum iron levels.

Authors:  Michael Li-Hsuan Huang; Christopher J D Austin; Marie-Agnès Sari; Yohan Suryo Rahmanto; Prem Ponka; Daniel Vyoral; Des R Richardson
Journal:  J Biol Chem       Date:  2013-07-11       Impact factor: 5.157

Review 9.  Alpha-2-Macroglobulin in Inflammation, Immunity and Infections.

Authors:  Jennifer Vandooren; Yoshifumi Itoh
Journal:  Front Immunol       Date:  2021-12-14       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.